International Clinical Trial: AI-Augmented Baduanjin Training and Postoperative Exercise Tolerance in Non-Small-Cell Lung Cancer Patients: A Prospective Cohort Study

Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119801) titled 'AI-Augmented Baduanjin Training and Postoperative Exercise Tolerance in Non-Small-Cell Lung Cancer Patients: A Prospective Cohort Study' on March 3.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: No. 253, Middle Industrial Avenue, Haizhu District, Guangzhou City, Guangdong Province

Condition: Non-small cell lung cancer

Intervention: Test group:Rehabilitation with Baduanjin using an AI-assisted real-time monitoring platform

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2024-08-23

Target Sample Size: Test group:28;Control group:28;

Countries of Recrui...